134 related articles for article (PubMed ID: 34521168)
1. [Prognostic value of the age-adjusted Charlson comorbidity index in patients over 60 years old with laryngeal squamous cell carcinoma].
Li ZL; An CM; Gao ZH; Cao JZ; Huangfu H; Nan J; Zhu BY; Zhang Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Aug; 56(8):837-843. PubMed ID: 34521168
[No Abstract] [Full Text] [Related]
2. Multivariate analysis of prognostic factors in patients with lip squamous cell carcinoma after surgery.
Cheng H; Xu JH; He JQ; Yang XY; Shen XN; Xu XL
World J Surg Oncol; 2024 Jan; 22(1):35. PubMed ID: 38279138
[TBL] [Abstract][Full Text] [Related]
3. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).
Fong PY; Tan SH; Lim DWT; Tan EH; Ng QS; Sommat K; Tan DSW; Ang MK
PLoS One; 2019; 14(11):e0224665. PubMed ID: 31747406
[TBL] [Abstract][Full Text] [Related]
4. The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients.
Di Donato V; Page Z; Bracchi C; Tomao F; Musella A; Perniola G; Panici PB
J Gynecol Oncol; 2019 Jan; 30(1):e6. PubMed ID: 30479090
[TBL] [Abstract][Full Text] [Related]
5. Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.
Takemura K; Takenaka Y; Ashida N; Shimizu K; Oya R; Kitamura T; Yamamoto Y; Uno A
Acta Otolaryngol; 2017 Dec; 137(12):1307-1312. PubMed ID: 28875745
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian Cancer.
Kahl A; du Bois A; Harter P; Prader S; Schneider S; Heitz F; Traut A; Alesina PF; Meier B; Walz M; Brueckner A; Groeben HT; Brunkhorst V; Heikaus S; Ataseven B
Ann Surg Oncol; 2017 Nov; 24(12):3692-3699. PubMed ID: 28871563
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
[TBL] [Abstract][Full Text] [Related]
8. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
[TBL] [Abstract][Full Text] [Related]
9. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma.
Pan Y; Liu ZP; Dai HS; Chen WY; Luo Y; Wang YZ; Gao SY; Wang ZR; Dong JL; Liu YH; Yin XY; Liu XC; Fan HN; Bai J; Jiang Y; Cheng JJ; Zhang YQ; Chen ZY
World J Gastrointest Oncol; 2023 Jun; 15(6):1036-1050. PubMed ID: 37389112
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer.
Dreyer J; Bremer M; Henkenberens C
Radiat Oncol; 2018 Nov; 13(1):213. PubMed ID: 30390700
[TBL] [Abstract][Full Text] [Related]
11. The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients.
Zhou S; Zhang XH; Zhang Y; Gong G; Yang X; Wan WH
Cancer Manag Res; 2022; 14():1683-1691. PubMed ID: 35573259
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer.
Wang Z; Zhong Y; Zhou Y; Mao F; Zhang X; Wang C; Sun Q
Clin Interv Aging; 2023; 18():1163-1174. PubMed ID: 37525754
[TBL] [Abstract][Full Text] [Related]
13. Age-adjusted Charlson comorbidity index as a prognostic factor of hypopharyngeal cancer treated with chemoradiation therapy.
Tanaka H; Takenaka Y; Nakahara S; Hanamoto A; Fukusumi T; Michiba T; Takemoto N; Cho H; Yamamoto M; Yamamoto Y; Inohara H
Acta Otolaryngol; 2017 Jun; 137(6):668-673. PubMed ID: 28084858
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of comorbidity and anemia on outcome in patients with sinonasal carcinoma.
Becker C; Dahlem KKK; Lange K; Ketterer MC; Pfeiffer J
J Craniomaxillofac Surg; 2018 Aug; 46(8):1373-1378. PubMed ID: 29807754
[TBL] [Abstract][Full Text] [Related]
15. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy.
Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Kobayashi S; Ueno M; Morimoto M; Shiozawa M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S116-S121. PubMed ID: 33380664
[TBL] [Abstract][Full Text] [Related]
16. Effect of the Age-Adjusted Charlson Comorbidity Index on the Survival of Esophageal Squamous Cell Carcinoma Patients after Radical Esophagectomy.
Song J; Lin Y; Zhang J; Liu S; Zhou J; Zeng Q; Lin Z; Fu R; Qiu M; Hu Z
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431214
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of comorbidities in patients with carcinoma of the major salivary glands.
Becker C; Dahlem KKK; Pfeiffer J
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1651-1657. PubMed ID: 27888340
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
[TBL] [Abstract][Full Text] [Related]
19. Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy.
Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
Eur J Surg Oncol; 2019 Dec; 45(12):2465-2472. PubMed ID: 31350072
[TBL] [Abstract][Full Text] [Related]
20. Age-adjusted Charlson Comorbidity Index (ACCI) is a significant factor for predicting survival after radical gastrectomy in patients with gastric cancer.
Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Huang CM; Zheng CH
BMC Surg; 2019 May; 19(1):53. PubMed ID: 31133008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
